ENTPD1 and follicular lymphoma: Hilchey et al. reported elevated levels of CD4+CD39+ T cells in lymph node mononuclear cells in human follicular lymphoma and blocking CD39 activity partially restored T cell hyporesponsiveness in some patients [31].